Details of the Drug Reposition

General Information of This Drug (ID: DMCGATN)

Drug Name
Apabetalone   DMCGATN
Synonyms
RVX 000222; 1044870-39-4; 2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one; RVX-000222; 2-[4-(2-Hydroxyethoxy)-3,5-Dimethylphenyl]-5,7-Dimethoxyquinazolin-4(3h)-One; UNII-8R4A7GDZ1D; RVX 000222; 8R4A7GDZ1D; QC-216; AK110565; Apabetalone [INN]; RVX000222; Apabetalone [USAN:INN]; 1K0; 4mr4; 4mr6; 4j1p; 4j3i; Apabetalone (USAN/INN); D0N7WW; SCHEMBL145019; GTPL7034; SCHEMBL17002023; AOB2133; DTXSID90146502; MolPort-027-835-445; NETXMUIMUZJUTB-UHFFFAOYSA-N; HMS3653C10; EX-A1110; BCP07787; ZINC4319
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cardiovascular disease DIS2IQDX BA00-BE2Z Phase 3 [1]
Cardiac events DIS311OG MC82 Phase 3 [2]
------------------------------------------------------------------------------------

References

1 Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.Nat Rev Drug Discov. 2016 Aug;15(8):533-50.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)